Exploring the role of type 3 resistant starch crystalline polymorphs in modulating gut health and alleviating inflammation in colitis

Puntos clave

• Type 3 resistant starch crystalline polymorphs significantly modulate gut health, reducing symptoms of colitis.
• Key evidence reveals a 30% reduction in inflammation markers over six weeks of treatment.
• Observational analysis on gut health efficacy suggests that resistant starch enhances microbiome diversity.
• Highlighting potential shifts in dietary approaches, these findings underline the importance of phytochemicals.